Plasma Cellular-Fibronectin Concentration Predicts Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic Stroke
- 1 July 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (7) , 1671-1676
- https://doi.org/10.1161/01.str.0000131656.47979.39
Abstract
Background and Purpose— Elevated plasma levels of cellular fibronectin (c-Fn) reflect vascular damage, so c-Fn might be a marker of secondary bleeding risk in cerebral ischemia. We investigated whe...Keywords
This publication has 13 references indexed in Scilit:
- Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human StrokeCirculation, 2003
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)Published by Elsevier ,1998
- Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/ReperfusionJournal of Cerebral Blood Flow & Metabolism, 1996
- Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in RatJournal of Cerebral Blood Flow & Metabolism, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Formulas for threshold computationsComputers and Biomedical Research, 1991
- Endotoxin‐induced endothelial injury and subendothelial accumulation of fibronectin in rat aortaThe Anatomical Record, 1991
- Modulation of endothelial fibronectin synthesisby polymorphonuclear granulocytesJournal of Cellular Physiology, 1989
- FibronectinsScientific American, 1986